A molecular journey on the pathogenesis of primary hyperoxaluria. [PDF]
Cellini B.
europepmc +1 more source
Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1. [PDF]
Zhang S, Gamallo P, Rawson V.
europepmc +1 more source
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease. [PDF]
Yang T +22 more
europepmc +1 more source
Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1. [PDF]
Gatticchi L +4 more
europepmc +1 more source
Primary hyperoxaluria type I diagnosed after a kidney transplant presenting with subcutaneous calcification: a case report of sodium thiosulfate treatment. [PDF]
Wu M +6 more
europepmc +1 more source
Primary hyperoxaluria type 3: from infancy to adulthood in a genetically unique cohort. [PDF]
Julius M +6 more
europepmc +1 more source
Unveiling primary Hyperoxaluria type 1: a fortuitous discovery through bone marrow biopsy. [PDF]
Aaboudech TY +6 more
europepmc +1 more source
The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis. [PDF]
Yu H, Zhong H, Liu Y, Zhang G.
europepmc +1 more source
Cutting through the stones: Unlocking therapeutic potential with gene editing tools for primary hyperoxaluria type 1. [PDF]
Schneller J, Du W, Ding H.
europepmc +1 more source

